While cytoplasmic overexpression of DDIT4 protein was shown in several studies to be a poor prognosis factor for tumor progression in ovarian carcinoma, acute myeloid leukemia, OSCC, and BUC22,28,33,65. This evidence concerns the gene DDIT4 and neoplasm.